Antagonist of interferon‐inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/<i>lpr</i> mice
Hitoshi Hasegawa(Tokyo Institute of Psychiatry), Masaki Yasukawa(Ehime Prefectural University of Health Science), Osamu Yoshie(Waseda University), Takashi Nakayama(Kindai University), Miho Terada(Ehime University), Atsushi Inoue(Astellas Pharma (Japan)), Masato Nose(Meiji University), Masatake Muraoka(Ehime University), Masashi Kohno(Ehime University), Tatsuhiko Miyazaki(Ehime University)
Cited by 55
Related Papers
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
|Immunity|1999|2.7k
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion
|Cell|1997|1.5k
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
Human host factors required for influenza virus replication
|Nature|2009|825
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
|Proceedings of the National Academy of Sciences|2002|398